NuVasive infringed five patents from a spine surgeon, a jury determined, according to an April 22 report from Bloomberg Law. The jury ruled that screw assemblies from the Reline, Armada and VuePoint ...

Globus Medical, Inc. shines with strong Q4 results & Nevro acquisition, boosting its market position. Click here to find out ...

Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the first quarter ended March 31, 2025 ...

In the dynamic landscape of healthcare innovation, the North America medical implant market emerges as a beacon of progress. With a projected annual growth rate of 6.6% in the forecast period, this ...

In an era marked by transformative healthcare advancements, the global medical implant market stands as a beacon of innovation and progress. With a projected annual growth rate of 7.1% over the period ...

Globus Medical is gearing up for a series of product launches throughout the Musculoskeletal portfolio in the coming months of 2025.

After starting his career holding numerous roles with increasing levels of responsibility at Medtronic Spine and Biologics, he was a senior executive at NuVasive from 2001 until 2015. Mr ...

Reflecting on the robust synergies from the NuVasive merger, we anticipate that the latest acquisition should positively impact the market sentiment toward GMED stock. Globus Medical has a market ...

The global Orthopedic Implants Market is valued at USD 47.38 Billion in 2024 and is projected to reach a value of USD 85.8 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of 5.55% between 2025 ...

As a result of the merger, Nevro is now a wholly owned subsidiary of Globus. According to InvestingPro data, Nevro maintained a healthy gross profit margin of 65.98% prior to the merger ...